CompletedNCT00940693
Duloxetine for adults with ADHD
About this title
Read the official source — NCT00940693This study evaluated the effectiveness of duloxetine for people with ADHD.
Medication studyAges 18–50Canada
Understand this study
What did researchers investigate?
This study evaluated the effectiveness of duloxetine for people with ADHD.
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- MontrealSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateAugust 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- Université de Montréal
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT00940693
- Official title
Show the full official title
Pilot Study of the Efficacy of Duloxetine in Treating Adults With Attention Deficit Hyperactivity Disorder: a Randomized, Controlled Trial.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Montreal
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the effectiveness of duloxetine for people with ADHD.
Who is behind this study?
The study sponsor is Université de Montréal, a university.
Did this study involve medication?
Yes. The study involved medication, including duloxetine and placebo.
Who was this study for?
Listed age limits: 18 years to 50 years.
